Screener
AbCellera Biologics Inc. ABCL Variable lease payments
Variable lease payments at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:VariableLeasePayment.
The source filing: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026.
- Filed
- Feb 24, 2026, 4:38 PM EST
- Fiscal year
- FY2025
- Accession
- 0001703057-26-000012
The Company incurred total operating lease expenses, including fixed lease payments, of $9.5 million, $9.1 million and $11.3 million, and variable lease payments of $1.1 million, $0.7 million and $0.5 million during the years ended December 31, 2023, 2024 and 2025, respectively, and are included within operating expenses.
Item 16. Form 10-K Summary
FAQ
- What is AbCellera Biologics Inc.'s variable lease payments?
- AbCellera Biologics Inc. (ABCL) reported variable lease payments of $125K in Q4 2025.
- How has AbCellera Biologics Inc.'s variable lease payments changed year-over-year?
- AbCellera Biologics Inc.'s variable lease payments decreased by 28.6% year-over-year, from $175K to $125K.
- What is the long-term trend for AbCellera Biologics Inc.'s variable lease payments?
- Over 2 years (2023 to 2025), AbCellera Biologics Inc.'s variable lease payments has grown at a -32.6% compound annual growth rate (CAGR), from $1.1M to $500K.
- What does variable lease payments mean?
- Variable lease payments as reported by AbCellera Biologics Inc. Common Shares.
Ask your AI about AbCellera Biologics Inc.'s variable lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude